[DOI] [PMC free article] [PubMed] [Google Scholar] 313.Debnath S., Agarwal A., Kumar N.R., Bedi A
Taken together, as there are no guidelines available for the tapering or discontinuation of current treatments of inflammatory diseases, we suggest that tapering DMARDs should, for one, be based on shared decision making with the patient being allowed to find individual ways of reducing the drug burden, as is currently shown for RA patients
The idea is that oral supplements may provide a systemic supply of the building blocks needed for the body to produce GHK-Cu naturally, but more research is needed to understand the effectiveness of this route
Certificates of Analysis serve as records documenting laboratory findings associated with specific product batches
Neurochemical Journal, 14 , 314-320